Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cerebyx approvable in USA

April 19, 1996

Myotrophin NDA submission on track

April 19, 1996

GP-3269, new AK inhibitor from Gensia

April 19, 1996

New dopamine D3 ligand from Warner-Lambert

April 19, 1996

P&U's U-99363E shows high affinity for D4 receptors

April 19, 1996

BASF reports dopamine D3 ligands

April 19, 1996

BDNF, CNTF protect against metabolic stress in vitro

April 12, 1996

Lubeluzole + DCLHb potentially effective in stroke

April 12, 1996

Hu23F2G advances to phase II

April 12, 1996

Neuronal cell protectant isolated from natural source

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 24, 2025.
Regulatory actions for April 24, 2025
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cel-Sci, Novavax,...
Go ask Alis? New fund aims to rescue biopharma’s trapped cash
BioWorld
“They are not zombies, they are fallen angels.” That is view of Nick Johnston, a U.K-based banker who has come up with a new plan to rescue listed companies whose...
Synthetic Design emerges with $20M and next-gen ADC platform
BioWorld
Synthetic Design Lab Inc., which emerged from stealth with a $20 million seed round and a platform technology aimed at advancing the antibody-drug conjugate (ADC)...